A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 276 participants.
Also called NCT07227532
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 276 participants
- Sponsor
- Registry
-
NCT07227532
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07227532. Allocation not applicable; no masking; primary purpose treatment. Start 2025-10-21 (actual); primary completion 2030-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Acronym
- AdmIREPAS
- Condition
- Atrial Fibrillation
- Intervention (Device)
- Pulsed Field Ablation by VARIPULSE Catheter with TRUPULSE Generator
- Lead sponsor
- Biosense Webster, Inc.
Record details
- Record id
cardio:ct-nct07227532- Content hash
e3207f64ec16feb7bda4f189e8bdf814d8b95f8aa579f6e918fdb8032574e87c